Xeris Biopharma Holdings Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$15.20

+2.12 (+16.21%)

As of Nov 7, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +206.9% upside

Low Target $35.62

Average Target $46.65

High Target $60.75

Current Price $15.20

Current
$15.20

Target
$46.65

$35.62 $46.65 avg $60.75

Scenario Analysis

Bear Case

$35.62

134.3%

Low target

Base Case

$46.65

+206.9%

Avg target

Bull Case

$60.75

+299.7%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.74

10.6% from high

52-Week Low

$5.25

+189.5% from low

Target vs 52W High

$46.65

+239.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	37	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	70%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	34	38%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	41%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	22	41%	$209.87	+164.3%